Publication date: Available online 18 July 2018
Source: The Spine Journal
Author(s): Jung Hwan Lee, Kyoung-ho Shin, Sung Jin Bahk, Goo Joo Lee, Dong Hwan Kim, Chang-Hyung Lee, Du Hwan Kim, Hee Seung Yang, Sang-Ho Lee
Abstract
Background Context
Epidural steroid injection (ESI) has been used to treat back or radicular pain from lumbar and lumbar and lumbosacral disc herniation (LDH). However, the superiority of transforaminal injection (TFESI) to caudal injection (CESI) remains controversial.
Purpose
This systematic review and meta-analysis aimed to investigate whether TFESI was more useful than CESI for achieving clinical outcomes in patients with LDH.
Study design/setting
A systematic review and meta-analysis/spine hospital and tertiary care hospital
Patient sample
Articles were chosen that compared the clinical efficacy of TFESI and CESI for treatment of low back and radicular leg pain caused by LDH.
Outcomes measures
Visual analogue scale, numeric rating scale, and Oswestry disability index
Methods
A literature search was performed using MEDLINE, EMBASE, Cochrane review, and KoreaMed databases for studies published until July 2017. After reviewing titles, abstracts, and full-texts of 6711 studies after initial database search, 6 studies were included in a qualitative synthesis. Data including pain score, functional score, and follow-up period were extracted from 4 studies and were analyzed using a random effects model to obtain effect size and its statistical significance. Quality assessment and evidence level were established in accordance with the Grading of Recommendations Assessment, Development and Evaluation (GRADE) methodology.
Results
Among 6 studies, 4 articles supported the superiority of TFESI to CESI, one article showed no significant difference, and one article supported the superiority of CESI to TFESI. To obtain compatible or superior clinical results to TFESI, CESI might need to inject a larger amount of medication than was usually used. A meta-analysis showed short-term and long-term trends toward better clinical efficacy with TFESI than with CESI without statistical significance. The evidence level was low because of inconsistency and imprecision.
Conclusion
Comprehensive reviews of selected articles revealed better clinical benefits with TFESI than with CESI, possibly because TFESI had the ability to deliver medication directly into the target area. Due to a low level of evidence and no significant results on meta-analysis, TFESI could be weakly recommended over CESI.
https://ift.tt/2Ljvukp
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.